Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Join Volition Veterinary at Netherlands Vet

Wednesday, March 11, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition Veterinary is inviting veterinary professionals to connect at the Netherlands Vet event. The focus will be on the Nu.Q® Vet Cancer Test for dogs, emerging data for felines, and advancements in epigenetic biomarkers. Attendees can access various resources to integrate these innovations into their practices.
Price reaction · baseline $4 (2026-03-10 close) · hit pre-market · clean, no other VNRX news in the window
day 0 close · peak
+1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Engagement opportunities for veterinary professionals.
  • Focus on innovative cancer testing for pets.
  • Emphasis on epigenetic biomarkers and their applications.

Full Press Release Details

Whether you’re interested in current Nu.Q ® Vet Cancer Test applications for dogs, emerging feline data, or what’s next for epigenetic biomarkers, we’d love to connect.
Find out more information:
• Nu.Q ® Vet Cancer Test Product Brochure (US)
• High Nu.Q ® Vet Cancer Test Result Guide
• How to integrate the Nu.Q ® Vet Cancer Test into your hospital/clinic workflow
• Cats preanalytics study
• Stay up to date: cats

Related Articles

• Blog Celebrating Women in Science: Insights from the women working in science at Volition
• Press Releases Volition Sponsors Symposium at Veterinary Meeting and Expo

Celebrating Women in Science: Insights from the women working in science at Volition

Volition Sponsors Symposium at Veterinary Meeting and Expo

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for detecting cancer in dogs.

What topics will be covered at the Netherlands Vet event?

The event will focus on the Nu.Q® Vet Cancer Test, feline data, and epigenetic biomarkers.

How can I integrate the Nu.Q® Test into my practice?

Resources are available to help integrate the Nu.Q® Vet Cancer Test into your clinic workflow.

Is there information available for feline cancer testing?

Yes, emerging data on feline cancer testing will be discussed at the event.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Volition Veterinary Nu.Q Vet Cancer Test epigenetic biomarkers veterinary professionals cancer testing
Last updated: Mar 11, 2026

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk